Free Trial

Gain Therapeutics (GANX) SEC Filings & 10K Form

Gain Therapeutics logo
$1.84 +0.10 (+5.73%)
(As of 11/15/2024 ET)

Recent Gain Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
3:02 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
4:22 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
3:30 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
5:15 AM
Gain Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/06/2024
4:00 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
4:01 PM
Gain Therapeutics (Filer)
Form 424B5
08/12/2024
4:23 PM
Gain Therapeutics (Issuer)
Islam Khalid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:23 PM
Gain Therapeutics (Issuer)
Mack Gene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
4:24 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
4:18 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
8:15 AM
Gain Therapeutics (Subject)
Form FWP
06/26/2024
8:30 PM
Gain Therapeutics (Issuer)
Riley Jeffrey Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
8:30 PM
Gain Therapeutics (Issuer)
RICHMAN ERIC I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
8:30 PM
Gain Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
8:30 PM
Gain Therapeutics (Issuer)
Nicaise Claude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
8:30 PM
Gain Therapeutics (Issuer)
HASLER HANS PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
8:30 PM
Gain Therapeutics (Issuer)
Melincoff Gwen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
8:30 PM
Gain Therapeutics (Issuer)
Islam Khalid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:20 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
7:30 AM
Gain Therapeutics (Filer)
Form 424B5
06/14/2024
3:40 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
3:38 PM
Gain Therapeutics (Filer)
Form 424B5
05/14/2024
3:03 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:06 PM
Gain Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/08/2024
6:42 PM
Gain Therapeutics (Issuer)
Mack Gene (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/08/2024
6:44 PM
Gain Therapeutics (Issuer)
Mack Gene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:23 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
8:00 PM
Alder Matthias (Reporting)
Gain Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
3:05 PM
Gain Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2024
8:30 PM
Alder Matthias (Reporting)
Gain Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
8:30 PM
Fuggetta Gianluca (Reporting)
Gain Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
6:00 AM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
4:26 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
3:09 PM
Gain Therapeutics (Filer)
Form 424B3
01/01/2024
11:15 PM
Gain Therapeutics (Filer)
Form EFFECT
12/19/2023
3:52 PM
Gain Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/24/2023
5:07 AM
Gain Therapeutics (Filer)
Form 424B5
11/22/2023
4:27 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2023
3:22 PM
Gain Therapeutics (Filer)
Form 424B5
11/17/2023
3:27 PM
Gain Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GANX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners